Your browser is no longer supported. Please, upgrade your browser.
Settings
MDT [NYSE]
Medtronic plc
IndexS&P 500 P/E45.03 EPS (ttm)2.59 Insider Own0.10% Shs Outstand1.34B Perf Week-2.42%
Market Cap155.90B Forward P/E20.05 EPS next Y5.83 Insider Trans-6.10% Shs Float1.34B Perf Month1.67%
Income3.50B PEG4.48 EPS next Q1.15 Inst Own83.40% Short Float0.42% Perf Quarter8.64%
Sales27.87B P/S5.59 EPS this Y2.30% Inst Trans0.02% Short Ratio1.27 Perf Half Y18.49%
Book/sh37.31 P/B3.13 EPS next Y38.71% ROA3.80% Target Price129.04 Perf Year-1.72%
Cash/sh10.70 P/C10.92 EPS next 5Y10.05% ROE7.00% 52W Range72.13 - 122.15 Perf YTD-0.28%
Dividend2.32 P/FCF89.24 EPS past 5Y7.70% ROI6.70% 52W High-4.37% Beta0.72
Dividend %1.99% Quick Ratio1.80 Sales past 5Y7.40% Gross Margin65.10% 52W Low61.94% ATR2.06
Employees90000 Current Ratio2.20 Sales Q/Q-0.80% Oper. Margin11.70% RSI (14)53.35 Volatility1.64% 1.63%
OptionableYes Debt/Eq0.60 EPS Q/Q-64.20% Profit Margin12.70% Rel Volume1.27 Prev Close117.77
ShortableYes LT Debt/Eq0.52 EarningsNov 24 BMO Payout84.90% Avg Volume4.46M Price116.81
Recom1.90 SMA200.26% SMA503.13% SMA20013.54% Volume5,653,311 Change-0.82%
Dec-15-20Upgrade Morgan Stanley Equal-Weight → Overweight $140
Dec-15-20Upgrade Goldman Sell → Neutral $100 → $119
Oct-08-20Upgrade Stifel Hold → Buy $125
Oct-08-20Upgrade Bernstein Mkt Perform → Outperform
Sep-11-20Initiated Wolfe Research Peer Perform $115
May-14-20Downgrade DZ Bank Buy → Hold $92
Mar-30-20Downgrade Needham Strong Buy → Buy $134 → $109
Mar-25-20Upgrade DZ Bank Hold → Buy $90
Mar-05-20Initiated Citigroup Buy $124
Feb-13-20Initiated Goldman Sell $118
Jan-08-20Initiated SunTrust Buy $130
Jan-02-20Upgrade Guggenheim Neutral → Buy $135
Jun-05-19Upgrade Wells Fargo Market Perform → Outperform
Feb-04-19Reiterated Needham Strong Buy $120 → $117
Jan-03-19Initiated Deutsche Bank Buy $99
Jan-02-19Downgrade Citigroup Buy → Neutral
Dec-19-18Upgrade JP Morgan Neutral → Overweight
Nov-28-18Initiated UBS Buy
Oct-16-18Initiated Barclays Overweight $113
Aug-27-18Reiterated Argus Buy $95 → $108
Jan-14-21 08:30AM  
08:30AM  
Jan-13-21 04:29PM  
07:14AM  
Jan-12-21 08:02PM  
08:13AM  
Jan-11-21 08:00AM  
Jan-08-21 06:30AM  
Jan-05-21 01:36PM  
06:57AM  
Jan-04-21 11:00AM  
11:00AM  
Dec-30-20 09:46AM  
Dec-28-20 06:00AM  
Dec-24-20 11:30AM  
07:08AM  
Dec-23-20 07:00AM  
Dec-22-20 10:00AM  
Dec-21-20 07:30AM  
03:32AM  
Dec-19-20 08:50AM  
Dec-16-20 02:01PM  
11:41AM  
08:00AM  
Dec-15-20 11:11AM  
10:04AM  
07:00AM  
Dec-14-20 04:30PM  
04:30PM  
06:45AM  
Dec-11-20 09:10AM  
Dec-10-20 07:00AM  
Dec-09-20 09:30AM  
Dec-08-20 12:55PM  
08:30AM  
08:30AM  
Dec-04-20 06:10PM  
Dec-01-20 02:32PM  
09:56AM  
02:40AM  
Nov-30-20 05:26PM  
01:00PM  
09:24AM  
Nov-29-20 02:49PM  
Nov-25-20 10:45AM  
08:35AM  
Nov-24-20 04:29PM  
02:19PM  
11:03AM  
08:16AM  
08:05AM  
07:30AM  
06:45AM  
01:44AM  
Nov-23-20 10:00AM  
09:37AM  
Nov-22-20 10:11AM  
Nov-19-20 10:24AM  
Nov-18-20 06:36AM  
Nov-17-20 09:03PM  
04:44PM  
12:30PM  
11:00AM  
10:13AM  
Nov-16-20 10:34AM  
08:56AM  
08:30AM  
Nov-13-20 05:56PM  
09:05AM  
08:30AM  
Nov-12-20 09:00AM  
Nov-11-20 07:45AM  
Nov-06-20 08:59AM  
Nov-04-20 12:51PM  
08:00AM  
Oct-29-20 09:05AM  
07:00AM  
Oct-27-20 06:00PM  
Oct-26-20 10:00AM  
08:00AM  
Oct-22-20 05:55AM  
Oct-21-20 01:25PM  
09:06AM  
08:00AM  
06:24AM  
Oct-20-20 07:30AM  
Oct-15-20 01:05PM  
08:24AM  
Oct-14-20 11:43AM  
09:41AM  
08:52AM  
08:52AM  
06:45AM  
Oct-13-20 11:00AM  
11:00AM  
Oct-11-20 12:47PM  
Oct-09-20 07:28PM  
06:14PM  
09:00AM  
Oct-08-20 08:44AM  
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Surface Carol ASVP, Chief HR OfficerDec 28Sale114.9015,0001,723,50034,150Dec 30 04:42 PM
Lerman Bradley ESVP General Counsel & Corp SecDec 22Sale115.562,605301,03451,543Dec 23 04:35 PM
WHITE ROBERT JOHNEVP & Pres. Medical SurgicalDec 18Sale115.4610,9301,261,97844,922Dec 21 05:06 PM
PARKHILL KAREN LEVP & Chief Financial OfficerDec 15Sale114.3367076,60186,897Dec 16 05:34 PM
Lerman Bradley ESVP General Counsel & Corp SecNov 09Option Exercise62.7620,7151,300,07374,863Nov 10 05:18 PM
Lerman Bradley ESVP General Counsel & Corp SecNov 09Sale113.1320,7152,343,48854,148Nov 10 05:18 PM
ISHRAK OMARExecutive ChairmanOct 09Sale108.4076382,709561,032Oct 14 06:38 PM
Lerman Bradley ESVP General Counsel & Corp SecOct 08Option Exercise62.7620,7141,300,01174,242Oct 09 05:12 PM
ANDERSON RICHARD HDirectorOct 08Buy108.524,607499,952101,673Oct 09 05:10 PM
Lerman Bradley ESVP General Counsel & Corp SecOct 08Sale110.0020,7142,278,54054,325Oct 09 05:12 PM
TEN HOEDT ROBEVP & President EMEASep 23Sale104.349,584999,99543,476Sep 25 05:42 PM
PARKHILL KAREN LEVP & Chief Financial OfficerSep 15Sale107.7870275,66287,366Sep 16 05:40 PM
TEN HOEDT ROBEVP & President EMEASep 09Sale105.059,5631,004,59353,060Sep 11 06:04 PM
Surface Carol ASVP, Chief HR OfficerMay 29Sale97.722,000195,44047,443Jun 02 05:39 PM
OLEARY DENISE MDirectorApr 03Option Exercise44.131,81380,00866,544Apr 07 06:17 PM
ISHRAK OMARChairman & CEOFeb 20Buy113.688,771997,087605,190Feb 24 08:56 AM